AGNG

Aging Population ETF

Overview Prices & Performance Holdings & Characteristics Research Documents

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2021

Key Information As of 09/29/22

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$37.25 million
NAV	$23.58
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 09/29/22

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	1,580,000
Number of Holdings	99
30-Day Median Bid-Ask Spread	0.37%

Distributions As of 09/29/22

30-Day SEC Yield	0.85%
Distribution Frequency	Semi-Annually

ETF Prices As of 09/29/22

NAV	$23.58	Daily Change	-$0.21	-0.88%
Market Price	$23.48	Daily Change	-$0.41	-1.72%

As of recent (06/30/22) As of recent (06/30/22)	Fund NAV	Market Price	Index
1 Year	-16.41%	-16.31%	-16.35%
3 Years	6.56%	6.66%	6.76%
5 Years	7.15%	6.97%	7.37%
Since Inception	9.42%	9.84%	9.70%
1 Year	-19.60%	-20.07%	-19.52%
3 Years	5.62%	5.32%	5.81%
5 Years	5.99%	5.81%	6.20%
Since Inception	8.72%	9.02%	8.99%
Year-to-Date	-12.15%	-11.85%	-12.11%
1 Month	-3.04%	-3.07%	-3.03%
3 Months	-11.63%	-11.39%	-11.61%
Since Inception	73.89%	78.04%	76.60%
Year-to-Date	-14.35%	-14.57%	-14.28%
1 Month	-6.00%	-6.66%	-6.02%
3 Months	-5.46%	-6.06%	-5.43%
Since Inception	69.54%	72.55%	72.23%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
4.01	LLY	ELI LILLY & CO	2516152	330.01	4,530	1,494,945.30
3.67	REGN	REGENERON PHARMACEUTICALS	2730190	691.82	1,977	1,367,728.14
3.55	BMY	BRISTOL-MYERS SQUIBB CO	2126335	71.71	18,457	1,323,551.47
3.41	AMGN	AMGEN INC	2023607	228.41	5,563	1,270,644.83
3.37	JNJ	JOHNSON & JOHNSON	2475833	164.53	7,632	1,255,692.96
3.29	BSX	BOSTON SCIENTIFIC CORP	2113434	39.34	31,161	1,225,873.74
3.24	NOVOB DC	NOVO NORDISK A/S-B	BHC8X90	100.43	12,002	1,205,393.90
3.17	RO SW	ROCHE HOLDING AG-BR	7108918	394.09	2,997	1,181,080.73
3.15	ABBV	ABBVIE INC	B92SR70	142.72	8,228	1,174,300.16
3.06	BIIB	BIOGEN INC	2455965	264.28	4,318	1,141,161.04
2.97	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	54.91	20,117	1,104,624.47
2.84	SYK	STRYKER CORP	2853688	205.48	5,155	1,059,249.40
2.83	4519 JP	CHUGAI PHARMA CO	6196408	25.10	41,923	1,052,460.25
2.74	MDT	MEDTRONIC PLC	BTN1Y11	82.27	12,421	1,021,875.67
2.67	ALC SW	ALCON INC	BJT1GR5	56.51	17,584	993,737.98
2.58	EW	EDWARDS LIFESCIENCES CORP	2567116	83.83	11,458	960,524.14
2.44	WELL	WELLTOWER INC	BYVYHH4	63.33	14,337	907,962.21
2.39	DXCM	DEXCOM INC	B0796X4	82.10	10,825	888,732.50
1.97	SGEN	SEAGEN INC	BLPK4D2	135.70	5,404	733,322.80
1.92	4503 JP	ASTELLAS PHARMA INC	6985383	13.17	54,162	713,569.69
1.78	ZBH	ZIMMER BIOMET HO	2783815	107.12	6,183	662,322.96
1.71	4543 JP	TERUMO CORP	6885074	28.41	22,414	636,790.43
1.67	GMAB DC	GENMAB A/S	4595739	318.88	1,951	622,143.01
1.30	068270 KS	CELLTRION INC	B0C5YV1	118.84	4,062	482,731.25
1.27	PODD	INSULET CORP	B1XGNW4	231.18	2,040	471,607.20
1.24	VTR	VENTAS INC	2927925	39.20	11,780	461,776.00
1.16	INCY	INCYTE CORP	2471950	66.61	6,505	433,298.05
1.11	BGNE	BEIGENE LTD-ADR	BYYWPW6	136.28	3,034	413,473.52
1.10	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	87.69	4,690	411,247.50
1.08	SOON SW	SONOVA HOLDING AG-REG	7156036	215.90	1,857	400,930.28
1.07	UCB BB	UCB SA	5596991	69.46	5,754	399,668.41
0.88	ABMD	ABIOMED INC	2003698	248.96	1,323	329,374.08
0.78	SN/ LN	SMITH & NEPHEW PLC	0922320	11.29	25,752	290,837.76
0.77	NBIX	NEUROCRINE BIOSC	2623911	102.76	2,798	287,522.48
0.75	TFX	TELEFLEX INC	2881407	203.97	1,374	280,254.78
0.75	UTHR	UNITED THERAPEUTICS CORP	2430412	207.94	1,346	279,887.24
0.75	3692 HK	HANSOH PHARMACEU	BJYKB72	1.60	174,743	279,147.15
0.75	AGL	AGILON HEALTH INC	BLR4TK4	23.52	11,817	277,935.84
0.71	COH AU	COCHLEAR LTD	6211798	134.92	1,950	263,101.25
0.65	AERI	AERIE PHARMACEUTICALS INC	BFRTDG1	15.12	15,907	240,513.84
0.64	FME GR	FRESENIUS MEDICA	5129074	27.75	8,637	239,647.21
0.64	DVA	DAVITA INC	2898087	83.96	2,838	238,278.48
0.63	NVCR	NOVOCURE LTD	BYSS4X4	77.05	3,057	235,541.85
0.57	CANO	CANO HEALTH INC	BN0WWW2	8.67	24,527	212,649.09
0.57	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	1.00	211,189	211,460.72
0.54	OHI	OMEGA HEALTHCARE	2043274	28.78	7,022	202,093.16
0.46	AMP IM	AMPLIFON SPA	B14NJ71	25.45	6,683	170,092.08
0.46	EXAS	EXACT SCIENCES CORP	2719951	33.17	5,115	169,664.55
0.45	DEMANT DC	DEMANT A/S	BZ01RF1	23.86	7,071	168,694.34
0.45	1858 HK	BEIJING CHUNLI-H	BVVPXP6	1.47	113,616	166,735.41
0.43	HALO	HALOZYME THERAPEUTICS INC	2975098	39.52	4,041	159,700.32
0.41	LHCG	LHC GROUP INC	B06DT50	164.29	928	152,461.12
0.40	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	46.73	3,209	149,956.57
0.40	EXEL	EXELIXIS INC	2576941	15.84	9,391	148,753.44
0.38	FGEN	FIBROGEN INC	BSDRYR8	13.26	10,772	142,836.72
0.38	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	10.11	14,126	142,813.86
0.37	CMAX	CAREMAX INC	BMD9BG0	7.60	18,033	137,050.80
0.36	LTC	LTC PROPERTIES INC	2498788	36.50	3,669	133,918.50
0.36	NHI	NATL HEALTH INVESTORS INC	2626125	55.31	2,418	133,739.58
0.35	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	80.95	1,629	131,867.55
0.35	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.33	399,692	131,365.41
0.35	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	28.57	4,587	131,050.59
0.35	ANGO	ANGIODYNAMICS INC	B00CR04	20.57	6,361	130,845.77
0.35	NHC	NATIONAL HEALTHCARE CORP	2139731	66.02	1,967	129,861.34
0.34	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	65.86	1,946	128,163.56
0.34	SBRA	SABRA HEALTH CAR	B5NLBP6	12.76	9,860	125,813.60
0.33	4547 JP	KISSEI PHARM CO	6494061	17.64	6,998	123,461.38
0.33	8086 JP	NIPRO CORP	6641599	7.52	16,413	123,385.53
0.33		CASH		1.00	121,771	121,781.85
0.32	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	57.07	2,115	120,703.05
0.32	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	29.29	4,113	120,469.77
0.32	GKOS	GLAUKOS CORP	BYMWL19	53.53	2,250	120,442.50
0.31	NUVA	NUVASIVE INC	B00GJC2	44.82	2,560	114,739.20
0.30	ITGR	INTEGER HOLDINGS CORP	BD06LM7	62.87	1,783	112,097.21
0.29	RYM NZ	RYMAN HEALTHCARE LTD	6161525	4.89	21,841	106,773.42
0.28	MNKD	MANNKIND CORP	BF081J4	2.99	34,982	104,596.18
0.28	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.28	375,824	104,370.29
0.27	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	1.75	58,302	102,048.37
0.27	INGN	INOGEN INC	BJSVLL5	24.08	4,156	100,076.48
0.27	AMED	AMEDISYS INC	2024332	100.45	986	99,043.70
0.25	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	8.49	11,019	93,602.65
0.25	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	8.71	10,683	93,048.93
0.25	ALEC	ALECTOR INC	BJ4LDC4	9.45	9,755	92,184.75
0.24	BKD	BROOKDALE SR	B0PZN33	4.29	20,413	87,571.77
0.24	HRTX	HERON THERAPEUTICS INC	BJ0XLZ3	4.01	21,823	87,510.23
0.23	CSH-U CN	CHARTWELL RETIRE	B8S8C94	6.63	13,142	87,105.46
0.23	PHM SM	PHARMA MAR SA	BMW2GT8	52.56	1,653	86,886.99
0.23	2500 HK	VENUS MEDTECH -H	BL6V047	1.20	71,440	85,547.08
0.23	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	4.84	17,616	85,312.30
0.22	LIVN	LIVANOVA PLC	BYMT0J1	48.37	1,721	83,244.77
0.22	ACAD	ACADIA PHARMACEU	2713317	16.14	5,045	81,426.30
0.22	PNTG	PENNANT GROUP INC/THE	BKTC976	10.76	7,520	80,915.20
0.21	AED BB	AEDIFICA	B1G5XP1	73.25	1,079	79,035.27
0.20	GN DC	GN STORE NORD A/S	4501093	17.65	4,240	74,842.69
0.19	SGHT	SIGHT SCIENCES INC	BN2T5Q6	6.10	11,513	70,229.30
0.17	KORI FP	KORIAN	B1HKRM0	9.73	6,349	61,759.37
0.13	DHC	DIVERSIFIED HEAL	BKRN595	0.99	47,487	47,183.08
0.11	AMRN	AMARIN CORP PLC -ADR	2301938	1.10	37,142	40,856.20
0.10	ORP FP	ORPEA	7339451	10.25	3,506	35,953.36
0.00		RADIUS HEALTH INC - CVR		0.00	19,104	0.00

Holdings are subject to change.

Sector Breakdown As of 08/31/22

	Sector	Weight (%)
	Health Care	93.5
	Real Estate	6.5

Source: AltaVista Research, LLC

Country Breakdown As of 08/31/22

	Country	Weight (%)
	United States	59.2
	Switzerland	8.7
	Japan	7.3
	Denmark	5.9
	Britain	4.9
	China	4.3
	Ireland	2.9
	South Korea	1.4
	Belgium	1.3
	Germany	0.8
	Australia	0.7
	Other/Cash	2.6

Source: AltaVista Research, LLC

ETF Characteristics As of 09/29/22

Return on Equity	12.70%
Weighted Avg. Market Cap	86,836 M
	2021	2022
Price-to-earnings	23.16	25.03
Price-to-book value	3.30	3.06

Source: AltaVista Research, LLC

ETF Risk Stats As of 08/31/22

Versus	Beta
S&P 500	0.76
MSCI EAFE	0.77
MSCI Emg. Mkts	0.62
Standard Deviation	18.20%

Source: AltaVista Research, LLC

ETF Research

ASCO Annual Meeting 2022: An Innovation Showcase in Cancer Treatment

Liquid Biopsy: A Pathway to Earlier and Less Invasive Cancer Detection

Latest Premium / Discount As of 09/29/22

NAV	$23.58
Market Price	$23.48
Premium / (Discount)	($0.10)

Current View 2022 Q3 As of 09/29/22

Days at Premium	41
Days at NAV	0
Days at Discount	22
Greatest Premium	0.76%
Greatest Discount	-0.54%

Daily Premium / Discount History As of 09/29/22

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Inception Date	Aug 24, 2022
Trailing 1 Month	--
Trailing 3 Months	--
Trailing 12 Months	--

Inception Date	Aug 24, 2022
Trailing 1 Month	--
Trailing 3 Months	--
Trailing 12 Months	--

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 09/29/22

ETF Summary

ETF Objective

Trading Details As of 09/29/22

Distributions As of 09/29/22

ETF Prices As of 09/29/22

Performance History

Top Holdings As of 09/29/22

Sector Breakdown As of 08/31/22

Country Breakdown As of 08/31/22

ETF Characteristics As of 09/29/22

ETF Risk Stats As of 08/31/22

ETF Research

ASCO Annual Meeting 2022: An Innovation Showcase in Cancer Treatment

Liquid Biopsy: A Pathway to Earlier and Less Invasive Cancer Detection

ETF Documents